Shiro Iwagami
Overview
Explore the profile of Shiro Iwagami including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
139
Citations
2234
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Naito Y, Iwagami S, Doi T, Takahashi T, Kurokawa Y
Int J Clin Oncol
. 2025 Feb;
PMID: 40019689
Background: Pimitespib, an oral heat shock protein 90 inhibitor, significantly prolonged progression-free survival in patients with advanced gastrointestinal stromal tumors (GIST) in CHAPTER-GIST-301 study. This expanded access program was conducted...
2.
Sakoh T, Eto K, Iwagami S, Yoshida N, Kosumi K, Iwatsuki M, et al.
Clin J Gastroenterol
. 2024 Mar;
17(3):419-424.
PMID: 38466470
Although patients with stage IV gastric cancer who respond well to systemic chemotherapy can be treated with gastrectomy, the prognosis of patients with multiple liver metastases is poor. We herein...
3.
Morito A, Eto K, Iwatsuki M, Toihata T, Kosumi K, Iwagami S, et al.
Ann Gastroenterol Surg
. 2024 Mar;
8(2):214-220.
PMID: 38455498
Background: The development and improved response to chemotherapy has resulted in a survival benefit of conversion surgery (CS) for advanced gastric cancer (GC). However, this benefit is limited in some...
4.
Kosumi K, Baba Y, Hara Y, Wang H, Nomoto D, Toihata T, et al.
Ann Surg Oncol
. 2024 Feb;
31(6):3839-3849.
PMID: 38421531
Background: Obesity is associated with increased mortality in various cancers, but the relationship between obesity and clinical outcomes in unresectable or recurrent esophageal cancer who receive immune checkpoint inhibitors (ICIs)...
5.
Yonemura A, Semba T, Zhang J, Fan Y, Yasuda-Yoshihara N, Wang H, et al.
Cell Rep
. 2024 Jan;
43(1):113613.
PMID: 38232734
Malignant ascites accompanied by peritoneal dissemination contain various factors and cell populations as well as cancer cells; however, how the tumor microenvironment is shaped in ascites remains unclear. Single-cell proteomic...
6.
Morito A, Iwatsuki M, Maeda Y, Mitsuura C, Hara Y, Matsumoto C, et al.
Langenbecks Arch Surg
. 2023 Aug;
408(1):324.
PMID: 37597037
Purpose: Textbook outcome (TO) is a composite quality measurement of short-term outcomes for evaluating surgical procedures. We investigated whether TO can be used to predict outcomes after curative gastric cancer...
7.
Maeda Y, Eto K, Yoshida N, Iwatsuki M, Iwagami S, Ogawa K, et al.
Geriatr Gerontol Int
. 2023 Aug;
23(10):750-756.
PMID: 37596938
Aim: The 5-factor modified frailty index (MFI-5) is a stratification tool to evaluate a patient's frailty. This study determined whether the MFI-5 is associated with short- and long-term outcomes after...
8.
Maeda Y, Iwatsuki M, Mitsuura C, Morito A, Ohuchi M, Kosumi K, et al.
Langenbecks Arch Surg
. 2023 Jun;
408(1):245.
PMID: 37354316
Purpose: Textbook outcome (TO) has been used to define achievement of multiple "ideal" or "optimal" surgical and postoperative quality measures from the patient's perspective. However, TO has not been reported...
9.
Baba Y, Hara Y, Toihata T, Kosumi K, Iwatsuki M, Iwagami S, et al.
Esophagus
. 2023 May;
20(4):704-712.
PMID: 37173453
Background: We previously demonstrated the relationship of human microbiome Fusobacterium nucleatum with unfavorable clinical outcomes and inferior chemotherapeutic responses in esophageal cancer. Global DNA methylation is associated with the occurrence...
10.
Akiyama T, Miyamoto Y, Matsuda A, Tokunaga R, Ogawa K, Iwatsuki M, et al.
J Cancer Res Clin Oncol
. 2023 Apr;
149(10):7887-7894.
PMID: 37058251
Purpose: Many systemic inflammatory markers have been identified to be prognostic factors in various diseases, including colorectal cancer (CRC). The Colon Inflammatory Index (CII), which is based on the lactate...